Philip A. Rovner
Partner

TEL: (302) 984-6140
FAX: (302) 658-1192
provner@potteranderson.com
vCard

Mr. Rovner specializes in the areas of commercial and complex litigation, representing a variety of corporate clients.  His commercial litigation practice focuses on intellectual property, product liability, insurance coverage, and contract disputes.  He is an experienced trial attorney, having served as trial counsel in a variety of intellectual property and commercial disputes in the United States District Court for the District of Delaware and Delaware’s state courts, including the Court of Chancery and the Superior Court.

Mr. Rovner was identified in the 2004, 2005 and 2006 editions of Chambers USA: America’s Leading Lawyers for Business in the area of intellectual property litigation.

Education

  • Fordham University, J.D., 1987
  • University of Pennsylvania, B.A., 1981

Representative Matters

  • Glaxo Wellcome Inc. v. Genentech, Inc. (D. Del.).  Counsel for Genentech in a successful patent infringement trial relating to two of Genentech’s leading oncology products, Herceptin® and Rituxan®; jury found that Genentech’s products did not infringe and that all of the patent claims that Glaxo asserted were invalid. 
  • PharmaStem Therapeutics, Inc. v. ViaCell, Inc.  (D. Del.).  Counsel for plaintiff in successful patent infringement trial relating to technology for collecting, cryopreserving and storing stem cells derived from umbilical cord and placental blood for future therapeutic use; obtained jury verdict, including a finding of willful infringement.
  • Freudenberg v. FiberVisions L.P. ( Del. Super.).  Lead trial counsel for defendant FiberVisions in successful defense of breach of contract action brought pursuant to Delaware Superior Court’s Summary Proceedings for Commercial Disputes procedures; judgment in FiberVisions’ favor after six-day bench trial before Judge Fred S. Silverman.
  • Baxter Healthcare Corporation v. Aventis Behring L.L.C. ( Del. Ch.).  Lead trial counsel for plaintiff Baxter in successful commercial case involving Baxter’s recombinant blood products.
  • Baxter Healthcare Corporation v. Genetics Institute, Inc. ( Del. Ch.).  Counsel for plaintiff Baxter in complex technical contract case involving recombinant blood proteins; settled after trial.

Professional Activities

  • Delaware State Bar Association
  • American Bar Association